Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple

Jannis Müller1,2,3, Sifat Sharmin1,2, Johannes Lorscheider3

  • 1CORe, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

JAMA Neurology
|April 14, 2025
PubMed
Abstract

Insights

Progression independent of relapse activity (PIRA) definitions vary, impacting multiple sclerosis (MS) research. A standardized PIRA definition is proposed to improve study comparability and understanding of disability accumulation in MS patients.

Area of Science:

  • Neurology
  • Clinical Research
  • Multiple Sclerosis (MS)

Background:

  • Progression independent of relapse activity (PIRA) significantly contributes to long-term disability in relapsing-remitting multiple sclerosis (MS).
  • Inconsistent PIRA definitions across studies hinder result comparability and understanding of disease progression.

Purpose of the Study:

  • To compare the impact of 360 distinct PIRA definitions on incidence and persistence.
  • To propose a standardized PIRA definition for enhanced research comparability in MS.

Main Methods:

  • Retrospective analysis of prospectively collected data from the MSBase registry (2004-2023).
  • Inclusion of 33,203 patients with clinically definite relapsing-remitting MS and at least three Expanded Disability Status Scale (EDSS) assessments.
  • Evaluation of 360 PIRA definitions based on baseline disability, confirmation period, magnitude, and relapse freedom criteria.

Main Results:

  • PIRA incidence varied from 0.141 to 0.658 events per decade, and persistence ranged from 0.753 to 0.919, highly dependent on the definition used.
  • Baseline and confirmation period criteria significantly influenced PIRA detection.
  • A proposed definition (disability worsening vs. reset baseline, no relapses since last EDSS, confirmed over 12 months) showed balanced incidence and persistence.

Conclusions:

  • The choice of PIRA definition critically impacts reported incidence and persistence rates in MS.
  • A standardized definition is crucial for improving the consistency and comparability of research findings in multiple sclerosis.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
323